Meeder Asset Management’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $38.6K | Sell |
77
-111
| -59% | -$53.3K | ﹤0.01% | 506 |
|
|
2026
Q1 | $92.4K | Buy |
188
+108
| +135% | +$58.6K | 0.01% | 374 |
|
|
2025
Q4 | $46.4K | Sell |
80
-2
| -2% | -$1.13K | ﹤0.01% | 404 |
|
|
2025
Q3 | $39.8K | Buy |
82
+2
| +3% | +$931 | ﹤0.01% | 335 |
|
|
2025
Q2 | $32.4K | Buy |
80
+12
| +18% | +$5.02K | ﹤0.01% | 441 |
|
|
2025
Q1 | $33.8K | Sell |
68
-28
| -29% | -$15.2K | ﹤0.01% | 452 |
|
|
2024
Q4 | $49.9K | Sell |
96
-3
| -3% | -$1.65K | ﹤0.01% | 360 |
|
|
2024
Q3 | $61.2K | Buy |
99
+5
| +5% | +$2.96K | ﹤0.01% | 337 |
|
|
2024
Q2 | $52K | Sell |
94
-479
| -84% | -$274K | ﹤0.01% | 338 |
|
|
2024
Q1 | $333K | Buy |
573
+69
| +14% | +$38.7K | 0.02% | 250 |
|
|
2023
Q4 | $268K | Sell |
504
-198
| -28% | -$95.8K | 0.02% | 240 |
|
|
2023
Q3 | $355K | Buy |
702
+98
| +16% | +$52.2K | 0.03% | 200 |
|
|
2023
Q2 | $315K | Sell |
604
-154
| -20% | -$83.1K | 0.02% | 227 |
|
|
2023
Q1 | $437K | Buy |
758
+68
| +10% | +$38.3K | 0.03% | 205 |
|
|
2022
Q4 | $380K | Sell |
690
-6,568
| -90% | -$3.48M | 0.03% | 280 |
|
|
2022
Q3 | $3.68M | Buy |
7,258
+344
| +5% | +$193K | 0.21% | 93 |
|
|
2022
Q2 | $3.76M | Sell |
6,914
-17,026
| -71% | -$9.37M | 0.22% | 92 |
|
|
2022
Q1 | $14.1M | Buy |
+23,940
| New | +$13.8M | 0.69% | 26 |
|
|
2021
Q4 | – | Sell |
-18,965
| Closed | -$10.8M | – | 2238 |
|
|
2021
Q3 | $10.8M | Buy |
18,965
+376
| +2% | +$206K | 0.57% | 34 |
|
|
2021
Q2 | $9.38M | Buy |
18,589
+3,798
| +26% | +$1.79M | 0.44% | 52 |
|
|
2021
Q1 | $6.75M | Buy |
14,791
+10,463
| +242% | +$4.99M | 0.35% | 63 |
|
|
2020
Q4 | $2.02M | Sell |
4,328
-10,114
| -70% | -$4.74M | 0.45% | 41 |
|
|
2020
Q3 | $6.38M | Buy |
14,442
+862
| +6% | +$356K | 0.41% | 56 |
|
|
2020
Q2 | $4.92M | Buy |
13,580
+6,282
| +86% | +$2.11M | 0.32% | 67 |
|
|
2020
Q1 | $2.07M | Buy |
7,298
+4,506
| +161% | +$1.42M | 0.16% | 120 |
|
|
2019
Q4 | $907K | Buy |
2,792
+2,204
| +375% | +$668K | 0.06% | 273 |
|
|
2019
Q3 | $171K | Sell |
588
-51
| -8% | -$14.6K | 0.01% | 643 |
|
|
2019
Q2 | $188K | Sell |
639
-598
| -48% | -$165K | 0.01% | 597 |
|
|
2019
Q1 | $338K | Buy |
1,237
+523
| +73% | +$130K | 0.03% | 448 |
|
|
2018
Q4 | $160K | Buy |
+714
| New | +$168K | 0.01% | 550 |
|
|
2018
Q2 | – | Sell |
-3,642
| Closed | -$752K | – | 1683 |
|
|
2018
Q1 | $752K | Buy |
+3,642
| New | +$764K | 0.07% | 287 |
|
|
2017
Q2 | – | Sell |
-6,473
| Closed | -$994K | – | 1870 |
|
|
2017
Q1 | $994K | Sell |
6,473
-23,892
| -79% | -$3.65M | 0.09% | 218 |
|
|
2016
Q4 | $4.28M | Buy |
30,365
+20,412
| +205% | +$3.01M | 0.41% | 73 |
|
|
2016
Q3 | $1.58M | Sell |
9,953
-4,371
| -31% | -$674K | 0.13% | 173 |
|
|
2016
Q2 | $2.12M | Buy |
14,324
+7,650
| +115% | +$1.13M | 0.2% | 109 |
|
|
2016
Q1 | $945K | Buy |
6,674
+5,674
| +567% | +$760K | 0.09% | 228 |
|
|
2015
Q4 | $141K | Buy |
+1,000
| New | +$133K | 0.01% | 584 |
|
|
2013
Q3 | – | Sell |
-105,270
| Closed | -$8.91M | – | 383 |
|
|
2013
Q2 | $8.91M | Buy |
+105,270
| New | +$8.76M | 1.77% | 7 |
|
Other funds holding TMO
Meeder Asset Management's TMO Position: Q2 2026 in Review
Meeder Asset Management reduced its Thermo Fisher Scientific (TMO) stake by 59% in Q2 2026, selling an estimated $53.3K and leaving 77 shares worth $38.6K. The position accounts for ﹤0.01% of the portfolio, ranked #506.
Meeder Asset Management first reported a position in TMO in Q2 2013 and has held it in 38 quarters since. The position peaked at $14.1M in Q1 2022. 2,615 funds tracked by Wall St. Rank hold TMO as of Q2 2026.
- Meeder Asset Management held 77 shares of Thermo Fisher Scientific worth $38.6K as of Q2 2026.
- Meeder Asset Management sold 111 Thermo Fisher Scientific shares in Q2 2026, an estimated $53.3K.
- Thermo Fisher Scientific made up ﹤0.01% of Meeder Asset Management's portfolio in Q2 2026, its #506 holding.
- Meeder Asset Management first reported a position in Thermo Fisher Scientific in Q2 2013 and has held it in 38 quarters since.
- Meeder Asset Management's Thermo Fisher Scientific position peaked at $14.1M in Q1 2022.
- 2,615 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.
Based on Meeder Asset Management's 13F filing for Q2 2026, filed 7 Aug 2026.